SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 13 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 7.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yakira Capital Management, Inc. | 108,485 | $11,326 | 0.00% |
| Shaolin Capital Management LLC | 465,717 | $49 | 0.00% |
| LMR Partners LLP | 539,588 | $56,333 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 9,365 | $977 | 0.00% |
| MORGAN STANLEY | 148,939 | $15,549 | 0.00% |
| Walleye Trading LLC | 15,505 | $1,619 | 0.00% |
| CLEAR STREET LLC | 100 | $0 | 0.00% |
| Walleye Capital LLC | 23,258 | $2,428 | 0.00% |
| Tower Research Capital LLC (TRC) | 48 | $5 | 0.00% |
| UBS Group AG | 100 | $10 | 0.00% |